GE HealthCare to buy SOFIE Biosciences for $945M in cash
GE HealthCare (Nasdaq: GEHC) has agreed to acquire SOFIE Biosciences, a U.S.-based contract manufacturing organization (CMO) for positron emission tomography ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

